This study aims to characterize individuals presenting with clinical features of CF in conjunction with at least one elevated sweat chloride (≥ 60 mmol/L) but without any CFTR variants identified following comprehensive genetic testing. The gene discussed is CFTR; the disease is cystic fibrosis.